Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Tick-Borne”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableLooking for participantsNCT03956446
What this trial is testing

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Who this might be right for
Tick Borne Encephalitis
University Medical Centre Ljubljana 80
Post-approval studies (Phase 4)Study completedNCT01106482
What this trial is testing

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Who this might be right for
Tick Borne Encephalitis (TBE)
Novartis Vaccines 126
Post-approval studies (Phase 4)Study completedNCT00161785
What this trial is testing

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer 340
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Testing effectiveness (Phase 2)Ended earlyNCT01031537
What this trial is testing

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Who this might be right for
Tick-Borne EncephalitisEncephalitis, Tick-BorneTick-Borne Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 69
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Post-approval studies (Phase 4)Study completedNCT00503529
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 314
Not applicableUnknownNCT05607394
What this trial is testing

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases

Who this might be right for
Tick-borne Encephalitis
University Hospital, Strasbourg, France 500
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableUnknownNCT00941590
What this trial is testing

Postencephalitic Symptoms After Tick Borne Encephalitis

Who this might be right for
Central European Encephalitis
University Medical Centre Ljubljana 200
Not applicableLooking for participantsNCT03418441
What this trial is testing

Central Nervous System Infections in Denmark

Who this might be right for
Central Nervous System InfectionsBacterial MeningitisViral Meningitis+9 more
Aalborg University Hospital 1,900
Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Large-scale testing (Phase 3)Study completedNCT00161876
What this trial is testing

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,973
Not applicableLooking for participantsNCT07274046
What this trial is testing

Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic

Who this might be right for
Tick Borne Encephalitis (TBE)
Charles University, Czech Republic 209
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Not applicableLooking for participantsNCT07191223
What this trial is testing

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Who this might be right for
Tick-borne Encephalitis, France
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Not applicableNot Yet RecruitingNCT06859619
What this trial is testing

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Who this might be right for
LeishmaniasisLeptospirosisBrucellosis+15 more
University Hospital, Montpellier 183
Load More Results